Status:
RECRUITING
Epidemiological Data on Mast Cell Pathologies in France
Lead Sponsor:
Imagine Institute
Conditions:
Mast Cell Disorder
Eligibility:
All Genders
Brief Summary
Mast cell disorders constitute a heterogeneous group of diseases, including : * mastocytosis, i.e. cutaneous, indolent and severe forms of the disease, such as aggressive mastocytosis and mast cell l...
Eligibility Criteria
Inclusion
- Children from birth and adults of any age
- With one of the following mast cell diseases:
- Mastocytoses (cutaneous, systemic and sarcomas) Defined according to the WHO 2016 classification
- Mast cell activation syndromes (idiopathic, secondary and clonal)
- Other mast cell activation disorders (MCAD-NOS), Defined according to the Vienna classification
- Pre-mastocytosis or MMC (1 to 2 criteria according to WHO 2016 classification).
- Managed in France in a rare disease reference, constitutive or competence center (CEREMAST) with DGOS labelization.
Exclusion
- 1\. Opposition of the patient or his/her parents to participation in the study.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2038
Estimated Enrollment :
13000 Patients enrolled
Trial Details
Trial ID
NCT06186856
Start Date
January 1 2024
End Date
December 31 2038
Last Update
December 19 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU AMIENS site sud
Amiens, France
2
Chu Angers
Angers, France, 49100
3
Chu - Besancon
Besançon, France, 25000
4
Chu - Caen
Caen, France, 14033